[Pathophysiology of primary hyperparathyroidism]

Area of Science:

• Endocrinology
• Oncology
• Genetics

Background:

• Primary hyperparathyroidism is characterized by increased parathyroid cell proliferation and parathyroid hormone (PTH) secretion.
• This occurs due to a loss of negative feedback regulation by calcium ions, leading to parathyroid tumor formation.
• Several genetic abnormalities are implicated in the pathogenesis of parathyroid tumors.

Purpose of the Study:

• To review the genetic factors contributing to parathyroid tumor development.
• To highlight key genes and mutations involved in primary hyperparathyroidism pathogenesis.
• To understand the molecular mechanisms underlying parathyroid tumorigenesis.

Main Methods:

• Literature review of genetic abnormalities in primary hyperparathyroidism.
• Analysis of gene mutations and chromosomal translocations associated with parathyroid tumors.
• Examination of the role of specific genes in parathyroid cell proliferation and PTH secretion.

Main Results:

• Activation of the cyclin D1 gene via chromosomal translocation is a cause of parathyroid tumorigenesis.
• Mutations in the multiple endocrine neoplasia type 1 (MEN1) gene are frequent in sporadic parathyroid tumors.
• Inactivation of tumor suppressor genes, including parafibromin, is crucial for tumor development.

Conclusions:

• Genetic abnormalities, including gene activation and mutations, play a significant role in primary hyperparathyroidism and parathyroid tumor formation.
• Genes such as cyclin D1, MEN1, parafibromin, calcium-sensing receptor, vitamin D receptor, Klotho, and RET are implicated.
• Understanding these genetic factors is essential for comprehending the molecular basis of the disease.